ADMA Adma Biologics Inc
ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.
$3.32 -0.01 (-0.15%)
As of 03/27/2023 14:02:18 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 10/17/2013
Outstanding shares: 196,777,308
Average volume: 2,948,349
Market cap: $611,977,428
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: B9NSBM2
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%